Clinical Trial Update: Consistency of Immunogenicity and Non Inferiority of GSK Biologicals' Candidate Malaria Vaccine Lots in Children [Phase 3]

View source ↗

Summary

A Phase 3 trial update reports consistency of immunogenicity and non-inferiority for GlaxoSmithKline's malaria vaccine lots in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• GSK Biologicals' malaria vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Malaria | Phase 3 | Status: COMPLETED | Results posted: 2017-08-07